The End Stage Renal Disease Treatment Choices Learning Collaborative is a national quality improvement initiative that brings together HRSA, CMS, transplant centers, OPOs, donor hospitals, and donor and recipient patients and families to generate increased quality and cost-savings using systematic quality and process improvement.
Message Box
icon
none
title
News and Updates
type
generic
Section
border
true
NATIONAL AIMS
Over a 5 year period the End Stage Renal Disease Treatment Choices Learning Collaborative intends to achieve the following national aims:
Column
width
15%
Increase the number of deceased donor kidneys transplanted by 15%.
Column
width
15%
Decrease the current national discard rate of all procured kidneys by 5%.
Column
width
15%
Increase the utilization of high KDPI kidneys recovered (60-85 KDPI Score) by 14%.
National Faculty provide subject matter expertise to advise ETCLC participants throughout the improvement process. Led by two National Chairpersons, the eleven national faculty represent transplant nephrologists and surgeons, Organ Procurement Organization professionals, donor hospitals, data analysts and statisticians, and patients.
The Leadership Coordinating Council is a group of 20 national stakeholders that guide the ETCLC. Members represent the kidney community, hospitals, dialysis services, quality improvement, social work, and patients.